NCT03668223View on ClinicalTrials.gov

The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

January 23, 2024

Study Completion Date

October 31, 2025

Conditions
CancerQuality of LifeAnxietyDepressionHopeCoping SkillsCommunication
Interventions
BEHAVIORAL

Promoting Resilience in Stress Management (PRISM)

Manualized skills training targeting resilience resources: stress-management, goal-setting, cognitive reframing, and meaning-making

Trial Locations (5)

15213

University of Pittsburgh Medical Center, Pittsburgh

77030

Texas Children's Hospital, Houston

98145

Seattle Children's Hospital, Seattle

900278

Children's Hospital Los Angeles, Los Angeles

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Children's Hospital Los Angeles

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

University of Pittsburgh Medical Center

OTHER

collaborator

Seattle Children's Hospital

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT03668223 - The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer | Biotech Hunter | Biotech Hunter